Speakers
private sector experience, Mr. Hopkins served 20 years in the United States Secret Service where he
completed his career as the Assistant Special Agent in Charge of the Houston Field Office. During his
career he fulfilled assignments in the Charlotte Field Office, Miami Field Office, Bush Protection Division,
Washington DC Headquarters, and the Houston Field Office. Mr. Hopkins received a Bachelor of Science
Degree in Criminal Justice from Auburn University and in 2011 he completed the Wharton School ASIS
Program for Security Executives. He currently serves on the Advisory Council for the International
Association of Financial Crimes Investigators and he is a member of the American Society for Industrial
Security (ASIS International), the International Security Management Association, the Overseas
Security Advisory Council (OSAC) the Domestic Security Advisory Council (DSAC) and the Security
Executive Council (SEC). Mr. Hopkins was selected in March 2015 as a member of the A-CAPP Advisory
Board.
Rich Kaeser
Rich Kaeser is the Vice President of Global Brand Protection at Johnson and Johnson. He leads J&J’s
enterprise-level brand protection function, with responsibility for combatting illicit trade across all J&J
business segments—pharmaceutical, medical device and consumer—and operating companies
worldwide. In his 25-year career with J&J, Rich has served in various leadership roles within J&J’s
medical device segment, including most recently as Vice President of US Sales for Cordis, a maker of
interventional cardiovascular and endovascular devices. Other prior commercial roles have included Vice
President of Strategic Customer Development for Johnson and Johnson Health Care Systems, Marketing
and Product Director for Ethicon Endo-Surgery’s (EES) bariatric surgery and Endocutter businesses, and
Director of Sales and Marketing for CardioVations, a division of Ethicon. He also led Ethicon’s renowned
Endo-Surgery Institute for two years. In his current role, Rich applies his extensive commercial go-to-
market and strategic planning experience toward developing and implementing effective brand
protection programs for J&J’s patients, consumers and brands. He is also the recipient of numerous
leadership awards from J&J and has served on several boards, including the American Society for
Bariatric Surgery and the Society for Cardiovascular and Interventional Radiology, and is currently the
co-chairman of Rx360 Supply Chain Security Committee.
Kari Kammel
Kari Kammel has a background in training, adult education, program management, and design spanning
multiple disciplines. Prior to working at A-CAPP, she worked at MSU, managing Middle East programs
for the Visiting International Professional Program, MSU. Before that, she was Deputy Chief of Party at
DePaul College of Law’s Iraq office, where she managed rule of law programs; and Deputy Executive
Director in the Chicago office. She is a licensed attorney in Illinois and Michigan and has experience
researching in intellectual property law, rule of law, and international criminal law. She holds a J.D. from
DePaul University, an M.A. in Political Science from the American University in Cairo, and a B.A. from
the University of Chicago. She is currently an Outreach Specialist for A-CAPP.
Jay P. Kennedy
Jay P. Kennedy is an Assistant Professor with the Center for Anti-Counterfeiting and Product Protection
and School of Criminal Justice at Michigan State University. He earned his Ph.D. in Criminal Justice at
the University of Cincinnati, where he was Graduate School Dean’s Distinguished Fellow, as well as a
Yates Scholar. While at the University of Cincinnati, Jay was awarded a Graduate Minority Fellowship
from the American Society of Criminology, and received several research grants and awards. A graduate
of the MBA program at the Carl H. Lindner College of Business, University of Cincinnati, his research
focuses upon deviance within corporations. Specifically, his research and published works explore issues
of employee theft within small businesses, the multi-level antecedents of corporate cr ime, and the role
12